ACL — Australian Clinical Labs Share News
0.000.00%
Last trade - 00:00- AU$529.23m
- AU$841.21m
- AU$735.75m
Australian Clinical Labs falls on $3.8 million penalty
Australian Clinical Labs soars on robust FY results, FY26 outlook
Brief: Australian Clinical Labs Posts FY Net Income AUD 32.8 Million
Brief: Australian Clinical Announces Final Dividend Of 9.0 AU CPS
Brief: Australian Clinical Labs Says Stephen Roche To Become Chair On 26 Aug
Brief: Australian Clinical Labs Says Mark Haberlin Appointed Interim Chair Of ACL Board
Australian Clinical Labs slumps on lower-than-expected results
Australia's Healius to sell diagnostic imaging arm to Affinity for $657 million (updated)
Australian Clinical Labs falls after biggest shareholder exits firm
Brief: Australian Clinical Labs Announces Sale Of Crescent Capital Shareholding
Brief: Australian Clinical Labs Appointed Matthew Cordingley As Chief Financial Officer
Australian Clinical Labs hits seven-month high on upbeat FY25 outlook
Brief: Australian Clinical Labs Says Final Dividend Of 9 AU Cents Per Share Declared
Australian Clinical Labs hits record low on poor FY forecast
Brief: Australian Clinical Labs Sees FY Results At Lower End Of Underlying EBIT Range Previously Provided
Australia's Healius jumps on review, CEO change amid shareholder value challenges (updated)
Australia's Healius jumps on review, CEO change
Australian Clinical Labs hits record low on narrowing H2 guidance
Brief: Australian Clinical Labs Declares Interim Dividend 3.00 AU CPS